FDA Updates Guidance On Avoiding Off-Label Promotion
Aiming to erase confusion, the U.S. Food and Drug Administration on Friday updated its policies on how drugmakers and medical device manufacturers can distribute scientific studies about unapproved uses of their...To view the full article, register now.
Already a subscriber? Click here to view full article